MEI Pharma (MEIP) Postpones Special Meeting
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Marvell shares jump after giving Google warrants amid custom chip deal
MEI Pharma Postpones Special Meeting of Shareholders
July 13, 2023 4:05 PM EDTSAN DIEGO--(BUSINESS WIRE)-- MEI Pharma, Inc. (NASDAQ: MEIP) (the Company) today announced that it has postponed its special meeting in connection with the proposed transaction with Infinity Pharmaceuticals, Inc. (Infinity) to July 23, 2023, at 10:00 a.m. Eastern Time, unless postponed or adjourned to a later date.
MEI issued the following statement:
With the postponement of the special meeting, MEI shareholders have additional time to consider the merits of and vote FOR the Infinity transaction.
As a reminder, independent leading proxy advisory firms, ISS and Glass... More
